PRISMA Study (Prospective, Randomized Trial on Intensive Self-Monitoring Blood Glucose Management Added Value in Non-Insulin Treated Type 2 Diabetes Mellitus Patients)

NCT00643474 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

1000

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus Type 2

Interventions

DEVICE: Accu-Chek Aviva Meter
DEVICE: Accu-Chek Aviva Meter

Sponsor

Hoffmann-La Roche